1 study found for:    21555100 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Enrolling by invitation The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation
Conditions: Antibody-mediated Rejection;   Hyperacute Rejection of Cardiac Transplant;   Left Ventricular Dysfunction;   Cardiac Allograft Vasculopathy;   Heart Graft Dysfunction
Intervention: Drug: Eculizumab

Indicates status has not been verified in more than two years